Sarcoma Alliance For Research Through Collaboration
Clinical trials sponsored by Sarcoma Alliance For Research Through Collaboration, explained in plain language.
-
Promising drug targets rare cancer in small trial
Disease control Recruiting nowThis phase 2 trial is testing a drug called nab-sirolimus in 41 people with a rare cancer called epithelioid hemangioendothelioma (EHE) that is growing or causing symptoms. The drug is given through an IV twice per cycle. The main goal is to see if it can shrink tumors. Researche…
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for rare sarcoma: targeted drug trial opens
Disease control Recruiting nowThis study tests a drug called tebentafusp in people with a rare and advanced type of cancer called clear cell sarcoma. Only patients with a specific genetic marker (HLA-A*02:01) can join. The goal is to see if the drug can stop the cancer from growing for at least 24 weeks. Abou…
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC